Max Nieuwdorp’s innovative research on gut microbes: a path to combat fatty liver disease
July 3, 2024Internist Max Nieuwdorp, of Amsterdam UMC, discovered a few years ago that the microorganisms in the intestines of many overweight people produce alcohol to an increased extent. Excessive alcohol leads to fatty liver disease, which in turn poses a risk of serious conditions such as diabetes and cardiovascular disease. Nieuwdorp has now received an ERC Advanced Grant of 2.5 million euros for a major study into the underlying causes of this excessive alcohol production.
Almost 1 in 5 adults in the Netherlands is overweight, and more than 80 percent of them have fatty liver disease. Max Nieuwdorp suspects that the high sugar content in modern diets contributes to increased alcohol production in the intestines. He hopes that discovering the link between a disrupted microbiome and increased alcohol production will pave the way for new treatments for fatty liver disease and liver inflammation.
Major study into gut bacteria
With the ERC Advanced Grant funding, Nieuwdorp aims to investigate whether it is possible to control alcohol production in the intestines by modifying intestinal bacteria to break down more alcohol. Now, he will delve deeper into this research by analyzing the medical data and eating patterns of participants in the long-term HELIUS study.
Support by IXA
The invention that a specific bacterium can convert alcohol into beneficial short-chain fatty acids, made by Max Nieuwdorp’s research group at Amsterdam UMC, was patented and a license agreement with Amsterdam UMC spin-off company Advanced Microbiome Interventions (AMI) was concluded by IXA Amsterdam UMC.
More news
VU researchers develop research equipment to identify contaminants in water
Water, comprising over 70% of our planet, is the source of all life. The presence of emerging contaminants in our water, including pharmaceuticals, pose serious health and environmental risks, such as DNA damage, reproductive issues, and cancer. New equipment to detect these contaminants developed by VU researchers has been sold to other research groups all over the world. Now the researchers are taking the next step, together with IXA, to expand sales to water companies worldwide as well as other applications such as food and drug discovery research.
News
Tackling learning difficulties in Academic Workplace
The Academic Workplace Rudolf Berlin Center (AW RBC) aims to make a meaningful contribution by supporting young people with learning disabilities through enhanced education and care.
News
Contribute to Amsterdam’s Future: test your innovation at SAIL and the Amsterdam Marathon
Are you looking for a testing ground for your innovation? SAIL and the Amsterdam Marathon present an excellent opportunity to test your ideas. These major events attract millions of visitors and come with sustainability, accessibility, and logistical challenges that need fresh solutions. The In Residence Events program allows you to test your innovation during these […]
News